Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06040827 · ClinicalTrials.gov registry record

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension

A clinical trial of Knee Osteoarthritis, sponsored by Canary Medical.

Recruiting
Registry status
626
Enrollment target
7
Study locations

NCT06040827 is a study of Knee Osteoarthritis that is actively recruiting participants, run by Canary Medical. The registered enrollment target is 626 participants, above the 298-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (110% higher). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06040827, a study of Knee Osteoarthritis, is actively recruiting participants, sponsored by Canary Medical.

RECRUITING
Registry status
626 participants
Enrollment target
7
Study locations

Study Summary

The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.

Conditions Studied

Interventions

  • DEVICE Total Knee Arthroplasty

Study Locations (7)

Ohio

  • Cleveland Clinic - Cleveland
  • JIS Research Institute - New Albany

Arkansas

  • Ozark Orthopaedics - Fayetteville

Florida

  • Foundation For Orthopaedic Research and Education - Tampa

Georgia

  • Northside Hospital - Atlanta

Indiana

  • South Bend Orthopaedics - South Bend

South Carolina

  • Carolina Orthopaedic & Neurosurgical Associates - Spartanburg

Trial Details

FieldValue
Enrollment Target 626 participants
Start Date 2023-09-12
Est. Completion 2028-12

Sponsor

Canary Medical

2 total trials

What the Registry Record Tells You About NCT06040827

The ClinicalTrials.gov registry entry for NCT06040827 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 626 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 298-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (110% higher). The listed sponsor is Canary Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Total Knee Arthroplasty is the first listed.

NCT06040827 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Ohio, Arkansas, Florida.

Frequently Asked Questions

What is clinical trial NCT06040827 about?

NCT06040827 is a clinical study titled "A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension". The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.

What is the current status of trial NCT06040827?

This trial is currently recruiting. The enrollment target is 626 participants. The study started on 2023-09-12. Estimated completion is 2028-12.

What conditions does trial NCT06040827 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT06040827?

The interventions under investigation include: Total Knee Arthroplasty (DEVICE).

Who is sponsoring clinical trial NCT06040827?

This trial is sponsored by Canary Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06040827 being conducted?

This trial has 7 study locations across Arkansas, Florida, Georgia, Indiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.